Francesco Lapi
Impact in
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 2%
Papers in
- Toxicology 20
- Pharmacovigilance and Adverse Drug Reactions 20
-
- Pharmaceutical Practices and Patient Outcomes 13
- Co-authors
- Claudio Alberto Cricelli (89 shared papers)Samy Suissa (6 shared papers)Pierre Ernst (3 shared papers)Valérie Patenaude (1 shared paper)Iacopo Cricelli (41 shared papers)Laurent Azoulay (4 shared papers)Hui Yin (3 shared papers)Alessandro Pasqua (12 shared papers)
- Journals
- Drug Safety (7 papers)Internal and Emergency Medicine (7 papers)European Journal of Clinical Pharmacology (6 papers)British Journal of Clinical Pharmacology (6 papers)Pharmacoepidemiology and Drug Safety (6 papers)
- Partner nations
- ItalyNetherlandsUnited Kingdom
In The Last Decade
Francesco Lapi
173 papers receiving 5k citations
Francesco Lapi's Hit Papers
Peers
Comparison fields: 5 of 150
- Geriatrics and Gerontology 338
- Family Practice 128
- Toxicology 206
- Nephrology 308
- Applied Microbiology and Biotechnology 65
Countries citing papers authored by Francesco Lapi
This map shows the geographic impact of Francesco Lapi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Lapi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Lapi more than expected).
Fields of papers citing papers by Francesco Lapi
This network shows the impact of papers produced by Francesco Lapi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Lapi. The network helps show where Francesco Lapi may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesco Lapi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhaled corticosteroids in COPD and the risk of serious pneumonia Hit paper breakdown → | 2013 | 364 |
| 2 | Trends in age‐related disease burden and healthcare utilization Hit paper breakdown → | 2018 | 302 |
| 3 | 2013 | 301 | |
| 4 | Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts Hit paper breakdown → | 2019 | 251 |
| 5 | 2018 | 218 | |
| 6 | 2019 | 213 | |
| 7 | 2009 | 151 | |
| 8 | 2016 | 119 | |
| 9 | 2013 | 101 | |
| 10 | 2021 | 97 | |
| 11 | 2010 | 95 | |
| 12 | 2013 | 90 | |
| 13 | 2008 | 83 | |
| 14 | 2017 | 82 | |
| 15 | 2014 | 73 | |
| 16 | 2017 | 73 | |
| 17 | 2018 | 71 | |
| 18 | 2017 | 70 | |
| 19 | 2012 | 65 | |
| 20 | 2020 | 63 |
About Francesco Lapi
Francesco Lapi is a scholar working on Toxicology, Geriatrics and Gerontology, Health Information Management, Pharmacology and Complementary and alternative medicine, having authored 183 papers that have together received 5.2k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (20 papers), Pharmaceutical Practices and Patient Outcomes (13 papers), Complementary and Alternative Medicine Studies (11 papers), Bone health and osteoporosis research (9 papers), Inflammatory mediators and NSAID effects (9 papers), Medication Adherence and Compliance (8 papers), Medical Coding and Health Information (8 papers) and Asthma and respiratory diseases (6 papers). The work is most often cited by research in Geriatrics and Gerontology (338 citations), Family Practice (128 citations), Toxicology (206 citations), Nephrology (308 citations) and Applied Microbiology and Biotechnology (65 citations). Francesco Lapi has collaborated with scholars based in Italy, Netherlands and United Kingdom. Frequent co-authors include Claudio Alberto Cricelli, Samy Suissa, Pierre Ernst, Valérie Patenaude, Iacopo Cricelli, Laurent Azoulay, Hui Yin, Alessandro Pasqua, Daniel Prieto‐Alhambra and Sharon J. Nessim. Their work appears in journals such as Drug Safety, Internal and Emergency Medicine, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.